Canaccord Genuity analyst Matt Bottomley maintains Canopy Gwth (TSX:WEED) with a Sell and lowers the price target from C$4.5 to C$3.5.
Sigilon Therapeutics Q3 EPS $(0.27) Up From $(0.63) YoY, Sales $4.25M Up From $1.95M YoY
Sigilon Therapeutics (NASDAQ:SGTX) reported quarterly losses of $(0.27) per share. This is a 57.14 percent increase over losses of $(0.63) per share from the same period last year. The company reported $4.25 million in
